| Construct anticancer drug-drug correlation network |
| Full text |
Pdf
(574 KB)
|
Source
|
Symposium on Applied Computing
archive
Proceedings of the 2009 ACM symposium on Applied Computing
table of contents
Honolulu, Hawaii
SESSION: Bioinformatics track
table of contents
Pages 771-775
Year of Publication: 2009
ISBN:978-1-60558-166-8
|
|
Authors
|
|
Jiao Li
|
Tsinghua University, Beijing, China and Purdue University School of Science, Indianapolis, IN
|
|
Pamela Crowell
|
Idaho State University, Pocatello ID
|
|
Jake Yue Chen
|
Indiana University School of Informatics, Purdue University School of Science, Indianapolis, IN
|
|
| Sponsor |
|
| Publisher |
|
| Bibliometrics |
Downloads (6 Weeks): 15, Downloads (12 Months): 59, Citation Count: 0
|
|
|
ABSTRACT
Network biology methods have been promising in linking diseases, genes, and drugs. In this study, we propose a novel computational method to construct drug-drug correlation networks, which consist of drug compounds as network graph nodes and correlated protein-drug profiles above a pre-determined threshold as network graph edges. This computational method is based on extensions of related work on identifying disease-specific proteins within protein-protein sub-networks, and mining protein-drug association profiles from biomedical literature. Our method provides a quantitative framework to compare how each drug compound from one therapeutic area is correlated with other drug compounds in other therapeutic areas, using a drug's protein-drug association profile mined from biomedical literature. We applied this method to the study of drug re-purposing and found that two breast cancer drugs "Mitomycin" and "Bleomycin" may be top drug candidates for treating pancreatic cancers.
REFERENCES
Note: OCR errors may be found in this Reference List extracted from the full text article. ACM has opted to expose the complete List rather than only correct and linked references.
| |
1
|
Imming, P., Sinning, C., and Meyer, A., Drugs, their targets and the nature and number of drug targets. Nature reviews Drug discovery, 2006. 5(10): p. 821--34.
|
| |
2
|
Yildirim, M. A., et al., Drug-target network. Nature biotechnology, 2007. 25(10): p. 1119--26.
|
| |
3
|
Goh, K. I., et al., The human disease network. Proceedings of the National Academy of Sciences of the United States of America, 2007. 104(21): p. 8685--8690.
|
| |
4
|
Hopkins, A. L., Network pharmacology. Nature biotechnology, 2007. 25(10): p. 1110--1.
|
| |
5
|
O'Connor, K. A. and Roth, B. L., Finding new tricks for old drugs: an efficient route for public-sector drug discovery. Nature reviews Drug discovery, 2005. 4(12): p. 1005--14.
|
| |
6
|
American Cancer Society, Cancer Facts & Figures 2008, Atlanta: American Cancer Society; 2008.
|
| |
7
|
Laheru, D. and Jaffee, E. M., Immunotherapy for pancreatic cancer - science driving clinical progress. Nature reviews Cancer, 2005. 5(6): p. 459--67.
|
 |
8
|
|
| |
9
|
Chen, J. Y., Shen, C., and Sivachenko, A. Y., Mining Alzheimer disease relevant proteins from integrated protein interactome data. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing, 2006: p. 367--378.
|
| |
10
|
Hamosh, A., et al., Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic acids research, 2005. 33(Database issue): p. D514--517.
|
| |
11
|
HAPPI: Human Annotated and Predicted Protein Interaction. http://discern.uits.iu.edu:8340/HAPPI/index.html.
|
| |
12
|
Li, J., et al. Learning Domain-Specific Knowledge from Context--THUIR at TREC2005 Genomics Track. in Proceedings of 14th Text Retrireval Conference (TREC2005). 2005. Gaithersburg, USA.
|
| |
13
|
MeSH: Medical Subject Headings (acess 2007). http://www.nlm.nih.gov/mesh/.
|
| |
14
|
Wu, C. H., et al., The Universal Protein Resource (UniProt): an expanding universe of protein information. Nucleic acids research, 2006. 34(Database issue): p. D187--91.
|
| |
15
|
Huan, T., et al., ProteoLens: a visual analytic tool for multi-scale database-driven biological network data mining. BMC Bioinformatics, 2008. 9(Suppl 9): p. S5.
|
| |
16
|
2008 MEDLINE/PubMed Baseline Data. http://www.nlm.nih.gov/bsd/licensee/2008_stats/baseline_doc.htm l.
|
| |
17
|
Mitomycin in Clinical Trials. http://clinicaltrials.gov/ct2/show/record/NCT00386399?term=Mit omycins&rank=11.
|
| |
18
|
Bleomycin in ClinicalTrhials http://clinicaltrials.gov/ct2/show/record/NCT00027521?term=Bleomycin&rank=14.
|
|